1. Teenage and young adult cancer
Dr. Novak Gupta

2. Q1 : WHAT IS TYA?
World Health Organization : adolescent as someone between 10–19 years of age, and youth as someone aged 15–24 years of age.
The National Cancer Institute (U.S.) : identifies 15- to 39-year age group, now referred by NCI as adolescents and young adults (AYA).
The National service delivery framework, Australia : defines ‘adolescents and young adults’ as young people between 15 and 25 years of age.
Indian context : age group of 15-30, is taken as Teenage and young adults

3. Q2: WHY FOCUS ON TYA’s? PATIENT FACTORS : DISEASE FACTORS
Age
Developmental issues
Psychological issues
Fertility
Dependence
Co -morbidities.
DISEASE FACTORS
Embryonal tumos early on
Epithelial tumors later on
No screening methods
may result from late effects of paediatric cancers
TREATMENT FACTORS
can tolerate intensive treatment
long term side effects

4. Our Study
We collected the data of Sri Aurobindo Medical College and P.G Institute for the year 2013.
A proforma was created and filled.
Education, economic status, duration of symptoms, contact with primary doctor and oncologist, treatment, abandonment, alive/ dead.
Tele- conversation with either the patient or the relative.
Period of study – May 2016 till date
Plan to collect data for patients till 2016

5. Telephonic conversation tried with – 85
Not responding/wrong numbers – 29
Total data for – 56

6. SAIMS cancer patients (2013) - 1562
TYA patients 01 Jan to 31 Dec – 186
Male – 104
Female – 82
TYA : total ratio - 186/ = %
Paediatric cancers ( y2013) - 24
Pead : TYA ratio - 24/186 = 1:8

7. Age distribution ( N = 186 ) AGE Number of cases
years (9%)
years (14%)
25-29 years (19%)
30-35 years (58%)

8. TYPE OF MALIGNANCY ( N = 186 )
Head and neck – 56
Tongue – 21
Buccal mucosa – 16
Lip – 3
Tonsil – 2
Others – 14
Breast – 28
Genito urinay – 23
Ovary – 9
Cervix – 7
RCC – 2
Prostate – 1
Vagina – 1
Testicular – 2
Uterus – 1
CNS - 22
Hematological – 22
HD – 5
ALL – 4
NHL – 5
CML – 3
Others – 5
Sarcomas – 20
Bone sarcoma – 16
Soft tissue – 4
GIT – 10
Anorectal – 5
Stomach – 2
Esophagus – 2
Colon - 1
Thyroid – 2
Melanoma – 2
Lung - 1

9. ( N = 186 )

10. Abandonment Definition : Failure to start treatment
or to complete treatment
( N = 56 )
12 (21.4%)
Unknown :
15 (26.7%)
Completed treatment:
29 (51.7%)

11. Survival ( as of MAY 2016 ) N = 56 Alive : 27 (48.2%)
Unknown : 4 (7.4%)
Dead : 25 (44.6%)

12. 2016 Head and neck – 14 Sarcoma – 12
Breast -9
Colorectal -8
Gynaecological – 8
CNS -7
Renal -2
Thymoma -1
HCC – 1
Total number of TYA patients (till Sept ) : 102
Haematological : 40
ALL-18
NHL- 12
AML- 6
HD -4

13. VS

14. Comparison between 2013 and 2016
Abandonment - 12 (21.4%)
Dead - 25 (44.6%)
Abandonment – 7 (6.8%)
Dead – 13 (12.7%)